<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27-marinedrugs-17-00567">
 <label>27.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Emau</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Tian</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Oâ€™Keefe B</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Mori</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>McMahon</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Palmer</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Bekele</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Tsai</surname>
    <given-names>C.C.</given-names>
   </name>
  </person-group>
  <article-title>Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide</article-title>
  <source>J. Med. Primatol.</source>
  <year>2007</year>
  <volume>36</volume>
  <fpage>244</fpage>
  <lpage>253</lpage>
  <pub-id pub-id-type="doi">10.1111/j.1600-0684.2007.00242.x</pub-id>
  <pub-id pub-id-type="pmid">17669213</pub-id>
 </element-citation>
</ref>
